Watchdog warns of illegal weight loss medicines
Soaring demand for GLP-1 receptor agonists, commonly prescribed for diabetes and obesity, is driving a surge in the online sale of illegal medicines. The European Medicines Agency (EMA)… read more.
Soaring demand for GLP-1 receptor agonists, commonly prescribed for diabetes and obesity, is driving a surge in the online sale of illegal medicines. The European Medicines Agency (EMA)… read more.
Novartis will present new data from 34 abstracts across its oncology portfolio at the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin (October 17-21, 2025). “We… read more.
In an analysis by race, sex, age, and geography, alcohol-induced death rates in 2024 are nearly double those in 1999, with a sharp increase at the onset of the… read more.
NICE(UK): Guselkumab can be used as an option for previously treated moderately to severely active Crohn’s disease in adults, when: i) conventional or biological treatment: a) has not… read more.
A systematic review by Isobel Blanksby and Holly Carding found that menopausal symptoms had a significant impact on the well-being and productivity of NHS staff. Given that women… read more.
NICE (UK): Pembrolizumab with carboplatin and paclitaxel can be used, within its marketing authorisation, as an option for untreated primary advanced or recurrent endometrial cancer in adults. It… read more.
Scientists have uncovered how lymphatic vessels – the kidney’s ‘plumbing system’ – undergo dramatic changes during chronic transplant rejection, becoming structurally disorganised and spreading to unusual parts of… read more.
GLP-1 receptor agonist drugs protect against diabetic retinopathy, a common complication of diabetes that can lead to sight loss, suggests new research being presented at the annual meeting… read more.
Pharmacist-led menopause clinics in the NHS The provision of accessible and specialised menopause care within the National Health Service (NHS) has historically faced significant challenges, often leaving patients… read more.
Datroway (datopotamab deruxtecan) has been approved in China for the treatment of adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 negative (IHC 0, IHC 1+… read more.
A lack of soap is the most often reported barrier to effective hand hygiene—key to curbing the spread of infection—in shared community spaces, such as households, schools, and… read more.
NICE (UK): Idebenone is recommended, within its marketing authorisation, as an option for treating visual impairment in Leber’s hereditary optic neuropathy (LHON) in people 12 years and over…. read more.